Objective To determine the effectiveness of prostatectomy in reducing
symptom severity and bother and in improving disease-specific and gene
ral quality of life. Patients and methods A prospective, cohort study
was performed in National Health Service and private hospitals in the
Northern, Wessex, Mersey, and South-West Thames Health Regions which c
omprised 5276 men undergoing prostatectomy recruited by 101 of the 106
(96%) surgeons (specialist and non-specialist) performing prostatecto
my during a 6-month period. Patients were assessed using the American
Urological Association (AUA) Symptom Index Score, the AUA symptom both
er score, disease-specific and generic quality-of-life scores, the occ
urrence of adverse events (urinary incontinence, erectile impotence an
d retrograde ejaculation) and three global (general) questions on the
results of their treatment. The outcome was assessed 3 months after su
rgery, Results Prostatectomy was effective in reducing both symptoms (
initial mean score 20.1 reduced to 7.4, P<0.001) and symptom bother (i
nitial mean score 14.4 reduced to 4.3, P<0.001). Not all men experienc
ed a good reduction in symptoms; 121 (3.9%) were worse, 301 (9.6%) wer
e the same, and 721 (23%) experienced only slight improvement, The typ
e of operation, grade of principal operator and use of pre-operative i
nvestigations were not associated with the extent of symptomatic impro
vement. Changes in symptom severity were highly correlated with change
s in bothersomeness and disease-specific quality of life but not with
generic quality of life. A third of men who were continent before surg
ery reported some incontinence 3 months later, although only 6% found
it a problem. Two-thirds of men experienced retrograde ejaculation and
31% experienced some erectile impotence following surgery. Conclusion
s Prostatectomy is effective in reducing symptoms in most men. Men who
experience a substantial reduction in symptoms were more likely to re
port a favourable outcome. The study confirmed that approximately one-
third of men reported an unfavourable result 3 months after their oper
ation.